LDOS Cash & equivalents
Cash & equivalents at Leidos rose to $1.1B in fiscal 2026, the highest in the 5 years reported, from $849M in 2025.
Cash and cash equivalents at year end, as filed.
SOURCE: us-gaap:CashAndCashEquivalentsAtCarryingValue · EDGAR CompanyFacts · CIK 1336920 · EDGAR ↗ · FY2021–FY2026 · ANNUAL
FY2026$1.1B
FY2025 $849M
HIGH$1.1B FY2026
LOW$516M FY2022
History AS FILED · DERIVATION SHOWN WHERE DERIVED
| Fiscal year | Cash & equivalents | Change |
|---|---|---|
| FY2026 | $1.1B | +$259M |
| FY2025 | $849M | +$208M |
| FY2023 | $641M | +$125M |
| FY2022 | $516M | $-211M |
| FY2021 | $727M | — |
More SAME DATA, OTHER VIEWS
Cash & equivalents across coverage → · LDOS company view →
Revenue · Net income · Operating cash flow · Free cash flow · Capital expenditure · Total assets · Shareholders' equity · Total debt · Return on equity · Days sales outstanding
Not investment advice. Every figure on this page is an XBRL fact from the issuer's own SEC filings or an arithmetic over such facts with the method shown. No forecast is made; no posture is expressed.